⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IDYA News
IDEAYA Biosciences, Inc. Common Stock
IDEAYA Biosciences Announces Participation at the 2026 Jefferies Global Healthcare Conference
prnewswire.com
IDYA
B7-H3 Becomes The Hottest Antigen In Oncology, And One NK Engager Enters Clinic
prnewswire.com
IPHA
GTBP
GSK
SMMT
IDYA
A Cancer Antigen Long Thought Untouchable Is Suddenly the Hottest Target in Oncology
globenewswire.com
GTBP
SMMT
IDYA
RADX
Form 8-K
sec.gov
IDYA
Form 8-K
sec.gov
IDYA
IDEAYA Biosciences Reports First Quarter 2026 Financial Results and Provides Business Update
prnewswire.com
IDYA
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
prnewswire.com
IDYA
IDEAYA Biosciences to Initiate New Drug Application Submission from the Darovasertib OptimUM-02 Trial under the Oncology Center of Excellence Real-time Oncology Review (RTOR) Program
prnewswire.com
IDYA
IDEAYA Biosciences Announces Late-Breaking Abstract Oral Presentation at ASCO 2026 to Provide Complete Data from Phase 2/3 Registrational Trial (OptimUM-02) of Darovasertib in Combination with Crizotinib in 1L HLA*A2-Negative Metastatic Uveal Melanoma
prnewswire.com
IDYA
Form 8-K
sec.gov
IDYA